Stay updated with breaking news from Nasdaq Mgta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Magenta Therapeutics, Inc. (NASDAQ:MGTA – Free Report) are going to split on the morning of Thursday, September 7th. The 2-1 split was announced on Thursday, September 7th. The newly created shares will be issued to shareholders after the market closes on Thursday, September 7th. Magenta Therapeutics Price Performance Magenta Therapeutics stock opened at […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 495,600 shares, an increase of 21.2% from the May 15th total of 408,800 shares. Based on an average daily volume of 504,400 shares, the days-to-cover ratio is […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – Stock analysts at Wedbush boosted their Q2 2023 earnings per share (EPS) estimates for Magenta Therapeutics in a research report issued on Tuesday, May 16th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.19) for the quarter, up from their […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,060,000 shares, a drop of 10.9% from the March 31st total of 1,190,000 shares. Currently, 2.4% of the company’s shares are short sold. Based […]